UC to Educate Public During National Heart Month
Faculty members of the University of Cincinnati Academic Health Center are giving a series of public presentations Jan. 31 through Feb. 21 on the symptoms, treatment and prevention of heart failure.
Coordinated by Lynne Wagoner, MD, a professor in UCs cardiology division, the programs are sponsored by UCs
the
practice group and University Hospital in recognition National Heart Month.
The presentations, from 5:30 to 7:30 p.m. Tuesdays at the Marriott North in West Chester, are designed for both the general public and health professionals. Participation is free, but registration is requested.
Jan. 31: Heart failure, atrial fibrillation and coronary artery disease, with Dr. Wagoner and fellow cardiologists, Richard Callihan, MD, and Syed Najeed, MD.
Feb. 7: Metabolic syndrome, obesity, diabetes, and peripheral vascular disease, with endocrinologist Amanda Denney, MD, cardiologist Mohamed Effat, MD, and vascular surgeon Amy Reed, MD.
Feb. 14: Diseases that mimic heart disease, including pulmonary hypertension, sleep apnea, and shortness of breath, with cardiologist Tehmina Naz, MD, sleep expert Victoria Surdulescu, MD, and pulmonary and critical-care intensivist Elsie Pina, MD.
Feb. 21: Heart rhythm disorders and new medical or surgical treatments for atrial fibrillation, with cardiologists Jeff Brunfield, MD, and Mehran Attari, MD, and cardiovascular surgeon and director of the Center for Surgical Innovation, Randall Wolf, MD.
The Marriott North is located off Union Center Boulevard at 6168 Mulhauser Rd. Call (513) 558-1810 to register or visit
.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.